BMRA BIOMERICA INC

Nasdaq biomerica.com


$ 2.89 $ -0.02 (-0.69 %)    

Wednesday, 15-Oct-2025 15:59:50 EDT
QQQ $ 605.61 $ 0.00 (0 %)
DIA $ 463.97 $ 0.00 (0 %)
SPY $ 667.72 $ 0.00 (0 %)
TLT $ 90.88 $ 0.00 (0 %)
GLD $ 390.47 $ 0.00 (0 %)
$ 2.86
$ 2.84
$ 2.85 x 100
$ 2.96 x 100
-- - --
$ 2.08 - $ 10.16
20,536
na
8.21M
$ 0.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-14-2025 08-31-2025 10-Q
2 08-29-2025 05-31-2025 10-K
3 04-14-2025 02-28-2025 10-Q
4 01-14-2025 11-30-2024 10-Q
5 10-15-2024 08-31-2024 10-Q
6 08-28-2024 05-31-2024 10-K
7 04-12-2024 02-29-2024 10-Q
8 01-16-2024 11-30-2023 10-Q
9 10-12-2023 08-31-2023 10-Q
10 08-25-2023 05-31-2023 10-K
11 04-14-2023 02-28-2023 10-Q
12 01-13-2023 11-30-2022 10-Q
13 10-13-2022 08-31-2022 10-Q
14 08-29-2022 05-31-2022 10-K
15 04-14-2022 02-28-2022 10-Q
16 01-12-2022 11-30-2021 10-Q
17 10-14-2021 08-31-2021 10-Q
18 08-27-2021 05-31-2021 10-K
19 04-14-2021 02-28-2021 10-Q
20 01-14-2021 11-30-2020 10-Q
21 10-15-2020 08-31-2020 10-Q
22 08-31-2020 05-31-2020 10-K
23 04-14-2020 02-29-2020 10-Q
24 01-14-2020 11-30-2019 10-Q
25 10-15-2019 08-31-2019 10-Q
26 08-29-2019 05-31-2019 10-K
27 04-15-2019 02-28-2019 10-Q
28 01-14-2019 11-30-2018 10-Q
29 10-15-2018 08-31-2018 10-Q
30 08-29-2018 05-31-2018 10-K
31 04-16-2018 02-28-2018 10-Q
32 01-16-2018 11-30-2017 10-Q
33 10-16-2017 08-31-2017 10-Q
34 08-29-2017 05-31-2017 10-K
35 04-14-2017 02-28-2017 10-Q
36 01-17-2017 11-30-2016 10-Q
37 10-17-2016 08-31-2016 10-Q
38 08-29-2016 05-31-2016 10-K
39 04-14-2016 02-29-2016 10-Q
40 01-14-2016 11-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biomerica-q1-sales-1380m-down-from-1807m-yoy

Biomerica (NASDAQ:BMRA) reported $1.380 million in sales this quarter. This is a 23.63 percent decrease over sales of $1.807 mi...

 biomerica-launches-ai-powered-tool-to-help-ibs-patients-manage-symptoms-and-avoid-trigger-foods-identified-by-infoods-testing

New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFo...

 reported-earlier-biomericas-10-minute-h-pylori-home-test-approved-in-uae

10-minute home test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerH....

 reported-earlier-biomerica-has-been-granted-canadian-patent-number-3145879-titled-compositions-devices-and-methods-of-ibs-sensitivity-testing

https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3145879/summary.html

 biomericas-infoods-ibs-test-receives-ama-pla-code-advancing-path-to-insurance-reimbursement-and-wider-patient-access

PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insur...

 biomericas-infoods-ibs-test-featured-in-prestigious-journal-gastroenterology-as-landmark-peer-reviewed-study-demonstrates-symptom-improvement-in-ibs-patients-through-personalized-non-drug-dietary-therapy

Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Tes...

 biomerica-announces-real-world-results-showing-effectiveness-of-infoods-ibs-product-along-with-launch-of-proprietary-real-time-patient-feedback-system-to-enhance-symptom-tracking-and-improve-patient-outcomes

Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointesti...

 announces-the-co-and-its-clia-laboratory-partner-have-submitted-an-application-to-the-american-medical-association-cpt-editorial-panel-requesting-the-assignment-of-a-proprietary-laboratory-analysis-code-for-the-infoods-ibs-diagnostic-test

- Application represents milestone toward broadening patient access to inFoods IBS- inFoods® IBS pinpoints patient-specific foo...

 biomericas-fortel-ulcer-test-approved-for-sale-in-uae-enabling-rapid-10-minute-detection-of-helicobacter-pylori-a-class-1-carcinogen-linked-to-80-of-gastric-cancer-casesoffering-fast-accessible-diagnostic-tool-amid-growing-regional-gi-health-concerns

10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproxi...

 uae-ministry-of-health-and-prevention-approves-biomericas-fortel-kidney-disease-test-for-sale

Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidn...

 biomerica-q3-eps-006-up-from-011-yoy-sales-112m-up-from-102m-yoy

Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.06) per share. This is a 45.45 percent increase over losses of $(0.11)...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION